Sandbox:Roukoz: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 155: | Line 155: | ||
upper midback area is usually spared | upper midback area is usually spared | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Common nevus''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Common nevus''' | ||
Line 204: | Line 174: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Blue nevus''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Blue nevus''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 223: | Line 193: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Spitz nevus''' | ||
| style="background: #F5F5F5; padding: 5px;" | | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Solar lentigo''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 251: | Line 219: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Lentigo Maligna''' | ||
| style="background: #F5F5F5; padding: 5px;" | | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 262: | Line 231: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Lentigo Maligna Melanoma''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 275: | Line 241: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Sebaceous hyperplasia''' | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Lichen planus-like keratosis''' | ||
| style="background: #F5F5F5; padding: 5px;" | | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 316: | Line 271: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Seborrheic keratosis''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 327: | Line 281: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Actinic keratosis''' | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 341: | Line 291: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Nodular malignant melanoma''' | |||
| style="background: #F5F5F5; padding: 5px;" |Usually asymptomatic | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Lump that has been rapidly growing over the past weeks | |||
| style="background: #F5F5F5; padding: 5px;" |No more additional findings | |||
| style="background: #F5F5F5; padding: 5px;" |No more additional findings | |||
| style="background: #F5F5F5; padding: 5px;" |none | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Cells proliferate downwards through the skin (vertical growth) | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* | * Two-thirds arise in normal skin, the rest in existing moles | ||
* Genetic component in some cases with a positive family history | |||
* | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Amelanotic melanoma''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |Usually asymptomatic | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |Color usually pink, purple or normal skin color | ||
| style="background: #F5F5F5; padding: 5px;" |Usually have an asymmetrical shape with an irregular border | |||
| style="background: #F5F5F5; padding: 5px;" |Red, nonspecific lesion with slightly elevated borders | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 368: | Line 324: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Do not make melanin, so lesions are not pigmented | |||
* | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Superficial basal cell carcinoma ''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Scaly patch | |||
| style="background: #F5F5F5; padding: 5px;" |Erythematous lesion | |||
| style="background: #F5F5F5; padding: 5px;" |No more additional findings | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* large, hyperchromatic, oval nuclei and little cytoplasm | |||
* well differentiated and cells appear histologically similar to basal cells of the epidermis | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Sebaceous cell carcinoma''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |Yellow-nodule | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 396: | Line 353: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Suspected due to evidence of eyelash loss | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Actinic keratoses''' | ||
| style="background: #F5F5F5; padding: 5px;" |Pain | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Hyperkeratosis | |||
| style="background: #F5F5F5; padding: 5px;" |Erythema | |||
| style="background: #F5F5F5; padding: 5px;" |less pigmentation, and tend to be somewhat smaller in size. | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | |||
|- | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Pyogenic granuloma''' | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
| style="background: #F5F5F5; padding: 5px;" |Rapidly growing | |||
| style="background: #F5F5F5; padding: 5px;" |Red, dome-shaped | |||
| style="background: #F5F5F5; padding: 5px;" |Friable papule with a collarette of scale | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 410: | Line 381: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Bowenoid papulosis''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |multiple, red- to brown-colored, small papules that | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 422: | Line 393: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* primarily arise on genitals | |||
* induced by human papillomavirus (HPV) infection | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Psoriasis''' | ||
| style="background: #F5F5F5; padding: 5px;" |Flaking, inflammation | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Thick, white, silvery, or red patches of skin | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Chronic condition | |||
|- | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Pyoderma gangrenosum''' | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |Purulent ulcer | ||
| style="background: #F5F5F5; padding: 5px;" |Ragged and violaceous border | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 448: | Line 422: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Sebaceous Hyperplasia''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Lesions can be single or multiple lesions | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Yellowish, soft, small papules on the face | |||
| style="background: #F5F5F5; padding: 5px;" |Usually on the nose, cheeks, and forehead | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Allergic Contact Dermatitis''' | |||
| style="background: #F5F5F5; padding: 5px;" |Itchy rash | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Red rash | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 475: | Line 448: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Not contagious | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Atopic Dermatitis''' | ||
| style="background: #F5F5F5; padding: 5px;" |Itchy rash | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |Red rash | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |Fever | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 488: | Line 461: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Chronic and sometimes accompanied by asthma | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Juvenile xanthogranuloma''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Juvenile xanthogranuloma''' | ||
Line 514: | Line 488: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Mycosis fungoides | | style="background: #F5F5F5; padding: 5px;" |Mycosis fungoides | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Epithelioma cuniculatum''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Epithelioma cuniculatum''' | ||
Line 542: | Line 501: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Verrucous carcinoma on the plantar foot | | style="background: #F5F5F5; padding: 5px;" |Verrucous carcinoma on the plantar foot | ||
|} | |} | ||
SCC in situ: Frequently, there is associated thickening of the epidermis (acanthosis), as well as hyperkeratosis and parakeratosis of the stratum corneum. In contrast to SCC in situ, actinic keratoses demonstrate only partial-thickness epidermal dysplasia. | SCC in situ: Frequently, there is associated thickening of the epidermis (acanthosis), as well as hyperkeratosis and parakeratosis of the stratum corneum. In contrast to SCC in situ, actinic keratoses demonstrate only partial-thickness epidermal dysplasia. | ||
<references /> | <references /> |
Revision as of 23:51, 18 February 2019
Diseases | Clinical manifestations | Para-clinical findings | Additional findings | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Skin Examination | ||||||||||
Lab Findings | Histopathology | ||||||||||
Symptoms | Symptoms | Dermoscopic Findings | Skin exam 1 | Skin exam 2 | Skin exam 3 | Risk factors | Areas affected | Unique features | |||
Cutaneous squamous cell carcinoma in situ (Bowen's disease) |
|
|
|
|
|
|
|
|
| ||
Invasive squamous cell carcinoma |
|
|
|
|
|
|
|
same as above | same as above | same as above | |
Keratoacanthoma | Usually asymptomatic | White circles, keratin, blood spots, and white structureless zones | Initial lesion: small pink macule
Later: papular quality and eventually forms a circumscribed nodule. |
The periphery of the nodule tends to be skin-colored or mildly erythematous and may have accompanying telangiectasias | The center of the nodule typically demonstrates a prominent keratinous core. |
|
|
a history of rapid growth within weeks favors this diagnosis |
|
| |
Merkel cell carcinoma | Usually asymptomatic | Milky red areas; linear, irregular vessels; and polymorphous vessels | rapidly growing, painless, firm, nontender, shiny, flesh-colored or bluish-red, intracutaneous nodule | No more additional findings | No more additional findings | Older patients with light skin tones |
|
|
Blue-red, dome-shaped nodule | ||
Nodular basal cell carcinoma | Usually asymptomatic | Pearly papule with telangiectasias | Pink or flesh-colored papule | No more additional findings | none | Typically presents on the face | May have a "rolled" border, where the periphery is more raised than the middle. | Ulceration is frequent, and the term "rodent ulcer" refers to these ulcerated nodular BCCs | |||
Prurigo nodules | Usually asymptomatic | Firm, dome-shaped and itchy | ranging in size from a few millimeters to several centimeters and often symmetrically distributed | Nodules can be flesh-colored, erythematous, or brown/black | none |
|
Worsened by heat, sweating, or irritation from clothing |
|
Nodules range in number from few to hundreds
upper midback area is usually spared | ||
Common nevus |
|
|
|
||||||||
Blue nevus |
|
|
|
||||||||
Spitz nevus | |||||||||||
Solar lentigo | |||||||||||
Lentigo Maligna | |||||||||||
Lentigo Maligna Melanoma | |||||||||||
Sebaceous hyperplasia | |||||||||||
Lichen planus-like keratosis | |||||||||||
Seborrheic keratosis | |||||||||||
Actinic keratosis | |||||||||||
Nodular malignant melanoma | Usually asymptomatic | Lump that has been rapidly growing over the past weeks | No more additional findings | No more additional findings | none | Cells proliferate downwards through the skin (vertical growth) |
| ||||
Amelanotic melanoma | Usually asymptomatic | Color usually pink, purple or normal skin color | Usually have an asymmetrical shape with an irregular border | Red, nonspecific lesion with slightly elevated borders |
| ||||||
Superficial basal cell carcinoma | Scaly patch | Erythematous lesion | No more additional findings |
|
|||||||
Sebaceous cell carcinoma | Yellow-nodule | Suspected due to evidence of eyelash loss | |||||||||
Actinic keratoses | Pain | Hyperkeratosis | Erythema | less pigmentation, and tend to be somewhat smaller in size. | |||||||
Pyogenic granuloma | Rapidly growing | Red, dome-shaped | Friable papule with a collarette of scale | ||||||||
Bowenoid papulosis | multiple, red- to brown-colored, small papules that |
| |||||||||
Psoriasis | Flaking, inflammation | Thick, white, silvery, or red patches of skin | Chronic condition | ||||||||
Pyoderma gangrenosum | Purulent ulcer | Ragged and violaceous border | |||||||||
Sebaceous Hyperplasia | Lesions can be single or multiple lesions |
Yellowish, soft, small papules on the face |
Usually on the nose, cheeks, and forehead | ||||||||
Allergic Contact Dermatitis | Itchy rash | Red rash | Not contagious | ||||||||
Atopic Dermatitis | Itchy rash | Red rash | Fever | Chronic and sometimes accompanied by asthma | |||||||
Juvenile xanthogranuloma | Reddened, yellowish-tan color of lesions | Slightly raised bumps | Typically | ||||||||
Cutaneous T-cell lymphoma | Mycosis fungoides | ||||||||||
Epithelioma cuniculatum | Increased size | Verrucous carcinoma on the plantar foot |
SCC in situ: Frequently, there is associated thickening of the epidermis (acanthosis), as well as hyperkeratosis and parakeratosis of the stratum corneum. In contrast to SCC in situ, actinic keratoses demonstrate only partial-thickness epidermal dysplasia.